Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Alanine--tRNA Ligase, Mitochondrial (AARS-1) Antikörper

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch in ELISA, IF, WB und IHC. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN7111429

Kurzübersicht für Alanine--tRNA Ligase, Mitochondrial (AARS-1) Antikörper (ABIN7111429)

Target

Alanine--tRNA Ligase, Mitochondrial (AARS-1)

Reaktivität

Human

Wirt

  • 1
Kaninchen

Klonalität

  • 1
Polyklonal

Konjugat

  • 1
Unkonjugiert

Applikation

  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Immunofluorescence (IF), Western Blotting (WB), Immunohistochemistry (IHC)
  • Verwendungszweck

    AARS1 antibody

    Aufreinigung

    Immunogen affinity purified

    Reinheit

    ≥95 % as determined by SDS-PAGE

    Immunogen

    alanyl-tRNA synthetase

    Isotyp

    IgG
  • Applikationshinweise

    WB: 1:200-1:1000, IHC: 1:20-1:200, IF: 1:20-1:200

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Avoid repeated freeze / thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    -20°C for 12 months

    Haltbarkeit

    12 months
  • Target

    Alanine--tRNA Ligase, Mitochondrial (AARS-1)

    Andere Bezeichnung

    AARS1

    Hintergrund

    Synonyms: Alanine--tRNA ligase, cytoplasmic|Alanyl-tRNA synthetase (AlaRS)|Renal carcinoma antigen NY-REN-42|AARS1|AARS

    Background: AARS(alanyl-tRNA synthetase) is also named as AlaRS(alanine tRNA ligase 1, cytoplasmic), renal carcinoma antigen NY-REN-42 and belongs to the class-II aminoacyl-tRNA synthetase family. It can interpret the RNA code and attach specific aminoacids to the tRNAs that contain the cognate trinucleotide anticodons. AARS consists of three domains: the N-terminal catalytic domain, the editing domain and the C-terminal C-Ala domain. The editing domain removes incorrectly charged amino acids, while the C-Ala domain, along with tRNA(Ala), serves as a bridge to cooperatively bring together the editing and aminoacylation centers thus stimulating deacylation of misacylated tRNAs(PMID:19661429).

    Molekulargewicht

    107 kDa

    Gen-ID

    16

    UniProt

    P49588
Sie sind hier:
Chat with us!